Prodrugs: A challenge for the drug development.

Journal Title: Pharmacological Reports - Year 2013, Vol 65, Issue 1

Abstract

It is estimated that about 10% of the drugs approved worldwide can be classified as prodrugs. Prodrugs, which have no or poor biological activity, are chemically modified versions of a pharmacologically active agent, which must undergo transformation in vivo to release the active drug. They are designed in order to improve the physicochemical, biopharmaceutical and/or pharmacokinetic properties of pharmacologically potent compounds. This article describes the basic functional groups that are amenable to prodrug design, and highlights the major applications of the prodrug strategy, including the ability to improve oral absorption and aqueous solubility, increase lipophilicity, enhance active transport, as well as achieve site-selective delivery. Special emphasis is given to the role of the prodrug concept in the design of new anticancer therapies, including antibody-directed enzyme prodrug therapy (ADEPT) and gene-directed enzyme prodrug therapy (GDEPT).

Authors and Affiliations

Jolanta Zawilska, Jakub Wojcieszak, Agnieszka Olejniczak

Keywords

Related Articles

Metabolic and monocyte-suppressing actions of fenofibrate in patients with mixed dyslipidemia and early glucose metabolism disturbances.

The aim of this study was to compare the action of fenofibrate on monocyte cytokine release between patients with isolated mixed dyslipidemia and dyslipidemia coexisting with prediabetic states in relationship with its m...

NMDA/glutamate mechanism of magnesium-induced anxiolytic-like behavior in mice.

The anxiolytic-like activity of magnesium in mice during the elevated plus maze (EPM) has been demonstrated previously. In the present study, we examined the involvement of NMDA/glutamate receptor ligands on the magnesiu...

Drug-induced myopathies. An overview of the possible mechanisms.

Myopathy is usually a non-fatal muscle disease involving skeletal muscle weakness, tenderness and pain with the possibility of the plasma creatinine kinase elevation. There are many different types of myopathies, some of...

Endurance training increases exercise-induced prostacyclin release in young, healthy men - relationship with VO(2max).

In the present study, we evaluated the effect of 5 weeks of moderate-intensity endurance training on the basal and exercise-induced systemic release of prostacyclin (PGI(2)), as assessed by plasma 6-keto-PGF(1alpha) conc...

Evaluation of the antioxidative properties of lipoxygenase inhibitors.

Background: Oxidative stress is a component of many pathological conditions including neurodegenerative diseases and inflammation. An important source of reactive oxygen species (ROS) are lipoxygenases (LOX) - enzymes re...

Download PDF file
  • EP ID EP93250
  • DOI -
  • Views 120
  • Downloads 0

How To Cite

Jolanta Zawilska, Jakub Wojcieszak, Agnieszka Olejniczak (2013). Prodrugs: A challenge for the drug development.. Pharmacological Reports, 65(1), 1-14. https://europub.co.uk./articles/-A-93250